{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:19:22Z","timestamp":1775276362536,"version":"3.50.1"},"reference-count":204,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Psychedelic-assisted therapies (PATs) can produce rapid and sustained antidepressant effects, yet variability in response remains substantial. Identifying predictors and moderators is essential for optimising patient selection, preparation, and delivery. To map and synthesise the evidence on the predictors of antidepressant response to classic\/serotonergic psychedelics administered with psychotherapeutic support in adults with depressive disorders, including treatment-resistant depression. Following PRISMA-ScR principles, we conducted a scoping review of major biomedical and psychology databases (PubMed (MEDLINE), Embase, PsycINFO, and Web of Science) and trial registries (searches September\u2013October 2025), supplemented by reference-list screening. We included randomised trials, open-label studies, and naturalistic cohorts reporting associations between candidate predictors (baseline traits\/clinical features, set\/setting variables, acute in-session phenomenology, and biological measures) and validated depression outcomes. We charted study characteristics, analytic approaches (including moderation\/mediation where available), and indicators of robustness (e.g., adjustment for overall intensity, preregistration, external validation). A total of 48 studies were included in the review. Across study designs, process-level features during the dosing session were the most consistent correlates of antidepressant improvement. Greater emotional breakthrough, mystical\/unitive experiences, and ego dissolution-linked reappraisal\/insight generally predicted larger and more durable symptom reductions, whereas anxiety-dominant or dysphoric states tended to attenuate benefit, often independent of overall subjective intensity. Set and setting\u2014particularly a stronger therapeutic alliance and music experienced as resonant\u2014predicted both the emergence of therapeutically salient acute experiences and downstream clinical gains. Baseline moderators showed smaller and mixed effects: PTSD comorbidity sometimes weakened trajectories; extensive prior psychedelic exposure was associated with smaller incremental gains; demographics were typically uninformative. Converging biological findings associated better outcomes with markers consistent with increased neural flexibility and plasticity (e.g., less segregated network dynamics; EEG indices), alongside peripheral changes implicating neurotrophic, inflammatory, and HPA axis pathways. Current evidence suggests that antidepressant response in PATs is driven less by static patient characteristics and more by what occurs during dosing and how the context shapes that experience. Optimising preparation, alliance, and music; facilitating emotional breakthrough and meaning making; and mitigating anxious dysregulation are actionable levers. Future trials should harmonise measures, pre-specify and validate moderators\/mediators, intensively sample in-session experience and physiology, and report benefits and harms more consistently.<\/jats:p>","DOI":"10.3390\/ijms27052202","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T13:58:03Z","timestamp":1772114283000},"page":"2202","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Predictors of the Effectiveness of Psychedelics in Treating Depression\u2014A Scoping Review"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5320-3658","authenticated-orcid":false,"given":"James","family":"Chmiel","sequence":"first","affiliation":[{"name":"Faculty of Physical Culture and Health, Institute of Physical Culture Sciences, University of Szczecin, Al. Piast\u00f3w 40B blok 6, 71-065 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5503-3019","authenticated-orcid":false,"given":"Filip","family":"Rybakowski","sequence":"additional","affiliation":[{"name":"Department and Clinic of Psychiatry, Poznan University of Medical Sciences, 61-701 Pozna\u0144, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0140-6736(21)02143-7","article-title":"Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic","volume":"398","author":"Santomauro","year":"2021","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e063095","DOI":"10.1136\/bmjopen-2022-063095","article-title":"What are the treatment remission, response and extent of improvement rates after up to four trials of antidepressant therapies in real-world depressed patients? A reanalysis of the STAR*D study\u2019s patient-level data with fidelity to the original research protocol","volume":"13","author":"Pigott","year":"2023","journal-title":"BMJ Open"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/wps.21120","article-title":"Treatment-resistant depression: Definition, prevalence, detection, management, and investigational interventions","volume":"22","author":"McIntyre","year":"2023","journal-title":"World Psychiatry"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/070674370705200108","article-title":"Definition, assessment, and staging of treatment-resistant refractory major depression: A review of current concepts and methods","volume":"52","author":"Berlim","year":"2007","journal-title":"Can. J. Psychiatry"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/bs.apha.2020.05.002","article-title":"Relapse prevention in treatment-resistant major depressive disorder with rapid-acting antidepressants","volume":"89","author":"Singh","year":"2020","journal-title":"Adv. Pharmacol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/npp.2017.84","article-title":"The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future","volume":"42","author":"Goodwin","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neuropharm.2017.12.040","article-title":"Psychiatry & the psychedelic drugs. Past, present & future","volume":"142","author":"Rucker","year":"2018","journal-title":"Neuropharmacology"},{"key":"ref_8","first-page":"101809","article-title":"Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial","volume":"56","author":"Schindowski","year":"2022","journal-title":"EClinicalMedicine"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jama.2023.14530","article-title":"Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial","volume":"330","author":"Raison","year":"2023","journal-title":"JAMA"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"115531","DOI":"10.1016\/j.psychres.2023.115531","article-title":"Psilocybin-assisted therapy for depression: A systematic review and meta-analysis","volume":"329","author":"Haikazian","year":"2023","journal-title":"Psychiatry Res."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Li, L.J., Mo, Y., Shi, Z.M., Huang, X.B., Ning, Y.P., Wu, H.W., Yang, X.H., and Zheng, W. (2024). Psilocybin for major depressive disorder: A systematic review of randomized controlledstudies. Front. Psychiatry, 15.","DOI":"10.3389\/fpsyt.2024.1416420"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of Psilocybin versus Escitalopram for Depression","volume":"384","author":"Giribaldi","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"24m15449","DOI":"10.4088\/JCP.24m15449","article-title":"Results from a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder","volume":"86","author":"Goodwin","year":"2025","journal-title":"J. Clin. Psychiatry"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"119655","DOI":"10.1016\/j.jad.2025.119655","article-title":"Long-term outcomes of single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression\u201412-month data from an open-label pilot study","volume":"389","author":"Ellis","year":"2025","journal-title":"J. Affect. Disord."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.euroneuro.2016.05.001","article-title":"Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens","volume":"26","author":"Rickli","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_16","first-page":"120","article-title":"A High-Resolution In Vivo Atlas of the Human Brain\u2019s Serotonin System","volume":"37","author":"Beliveau","year":"2017","journal-title":"J. Neurosci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0006-8993(99)01224-X","article-title":"Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release","volume":"825","author":"Aghajanian","year":"1999","journal-title":"Brain Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"8846","DOI":"10.1523\/JNEUROSCI.20-23-08846.2000","article-title":"DOI-Induced activation of the cortex: Dependence on 5-HT2A heteroceptors on thalamocortical glutamatergic neurons","volume":"20","author":"Scruggs","year":"2000","journal-title":"J. Neurosci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics Promote Structural and Functional Neural Plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41593-023-01316-5","article-title":"Psychedelics promote plasticity by directly binding to BDNF receptor TrkB","volume":"26","author":"Moliner","year":"2023","journal-title":"Nat. Neurosci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1097\/CM9.0000000000002647","article-title":"Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity","volume":"136","author":"Du","year":"2023","journal-title":"Chin. Med. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e2022489118","DOI":"10.1073\/pnas.2022489118","article-title":"Harnessing psilocybin: Antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice","volume":"118","author":"Hesselgrave","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/s41386-022-01297-2","article-title":"Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects","volume":"47","author":"Holze","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00213-003-1640-6","article-title":"Acute psychological and physiological effects of psilocybin in healthy humans: A double-blind, placebo-controlled dose-effect study","volume":"172","author":"Hasler","year":"2004","journal-title":"Psychopharmacology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bbi.2023.09.004","article-title":"Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled study","volume":"114","author":"Mason","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/ejn.14720","article-title":"Neuroinflammation and depression: A review","volume":"53","author":"Troubat","year":"2021","journal-title":"Eur. J. Neurosci."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Shahar, O., Botvinnik, A., Esh-Zuntz, N., Brownstien, M., Wolf, R., Lotan, A., Wolf, G., Lerer, B., and Lifschytz, T. (2022). Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 Receptors in the Head Twitch Response Induced by 5-Hydroxytryptophan and Psilocybin: Translational Implications. Int. J. Mol. Sci., 23.","DOI":"10.1101\/2022.07.22.501026"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Ray, T.S. (2010). Psychedelics and the human receptorome. PLoS ONE, 5, Erratum in PLoS ONE 2010, 5, 10-1371. https:\/\/doi.org\/10.1371\/annotation\/e580a864-cf13-40c2-9bd9-b9687a6f0fe4.","DOI":"10.1371\/annotation\/e580a864-cf13-40c2-9bd9-b9687a6f0fe4"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"113612","DOI":"10.1016\/j.biopha.2022.113612","article-title":"Serotonin 5-HT2A, 5-HT2c and 5-HT1A receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response","volume":"154","author":"Horrillo","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"173903","DOI":"10.1016\/j.pbb.2024.173903","article-title":"Mescaline-induced behavioral alterations are mediated by 5-HT2A and 5-HT2C receptors in rats","volume":"245","author":"Danda","year":"2024","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1007\/s43440-023-00539-4","article-title":"Cardiovascular safety of psychedelic medicine: Current status and future directions","volume":"75","year":"2023","journal-title":"Pharmacol. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/02698811231225609","article-title":"Microdosing psychedelics and the risk of cardiac fibrosis and valvulopathy: Comparison to known cardiotoxins","volume":"38","author":"Rouaud","year":"2024","journal-title":"J. Psychopharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1080\/14740338.2023.2248883","article-title":"Serotonin 5-HT2B receptor agonism and valvular heart disease: Implications for the development of psilocybin and related agents","volume":"22","author":"McIntyre","year":"2023","journal-title":"Expert. Opin. Drug Saf."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1177\/02698811231190865","article-title":"The risk of chronic psychedelic and MDMA microdosing for valvular heart disease","volume":"37","author":"Tagen","year":"2023","journal-title":"J. Psychopharmacol."},{"key":"ref_35","first-page":"e63487","article-title":"Multiple Episodes of Cardiac Arrest Induced by Treatment with Ibogaine: A Case Report","volume":"16","author":"Mestre","year":"2024","journal-title":"Cureus"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Brunt, T.M. (2026). Rare but relevant: Ibogaine and cardiovascular complications-prolonged QT interval and ventricular arrhythmias. Addiction, Epub ahead of print.","DOI":"10.1111\/add.70319"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Steyerberg, E.W., Moons, K.G., van der Windt, D.A., Hayden, J.A., Perel, P., Schroter, S., Riley, R.D., Hemingway, H., Altman, D.G., and PROGRESS Group (2013). Prognosis Research Strategy (PROGRESS) 3: Prognostic model research. PLoS Med., 10.","DOI":"10.1371\/journal.pmed.1001381"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.7326\/M18-3667","article-title":"The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement","volume":"172","author":"Kent","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"DeRubeis, R.J., Cohen, Z.D., Forand, N.R., Fournier, J.C., Gelfand, L.A., and Lorenzo-Luaces, L. (2014). The Personalized Advantage Index: Translating research on prediction into individualized treatment recommendations. A demonstration. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0083875"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1146\/annurev-clinpsy-050817-084746","article-title":"Treatment Selection in Depression","volume":"14","author":"Cohen","year":"2018","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/wps.20882","article-title":"The promise of machine learning in predicting treatment outcomes in psychiatry","volume":"20","author":"Chekroud","year":"2021","journal-title":"World Psychiatry"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4088\/JCP.07m03780","article-title":"Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: A meta-analysis including 6562 patients","volume":"70","author":"Szegedi","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Ising, M., Maccarrone, G., Br\u00fcckl, T., Scheuer, S., Hennings, J., Holsboer, F., Turck, C.W., Uhr, M., and Lucae, S. (2019). FKBP5 Gene Expression Predicts Antidepressant Treatment Outcome in Depression. Int. J. Mol. Sci., 20.","DOI":"10.26226\/morressier.5d1a037257558b317a1402d8"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jad.2020.09.092","article-title":"Psychological Predictors of Cognitive-Behavioral Therapy Outcomes for Anxiety and Depressive Disorders in Children and Adolescents: A Systematic Review and Meta-Analysis","volume":"278","author":"Kunas","year":"2021","journal-title":"J. Affect. Disord."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/cpt.971","article-title":"Enrichment Strategies in Pediatric Drug Development: An Analysis of Trials Submitted to the US Food and Drug Administration","volume":"104","author":"Green","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Roseman, L., Nutt, D.J., and Carhart-Harris, R.L. (2018). Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression. Front. Pharmacol., 8.","DOI":"10.3389\/fphar.2017.00974"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1177\/02698811251346697","article-title":"Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depression","volume":"39","author":"Brudner","year":"2025","journal-title":"J. Psychopharmacol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s11469-024-01253-9","article-title":"Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder","volume":"22","author":"Weiss","year":"2024","journal-title":"Int. J. Ment. Health Addict."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jad.2024.12.061","article-title":"The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression","volume":"372","author":"Goodwin","year":"2025","journal-title":"J. Affect. Disord."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","article-title":"Psilocybin with psychological support for treatment-resistant depression: Six-month follow-up","volume":"235","author":"Bolstridge","year":"2018","journal-title":"Psychopharmacology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1177\/02698811241278873","article-title":"Naturalistic psychedelic therapy: The role of relaxation and subjective drug effects in antidepressant response","volume":"38","author":"Calder","year":"2024","journal-title":"J. Psychopharmacol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/02698811211073759","article-title":"Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up","volume":"36","author":"Gukasyan","year":"2022","journal-title":"J. Psychopharmacol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1177\/02698811231154852","article-title":"Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial","volume":"37","author":"Sloshower","year":"2023","journal-title":"J. Psychopharmacol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jad.2018.01.006","article-title":"Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression","volume":"230","author":"Carrillo","year":"2018","journal-title":"J. Affect. Disord."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/acps.12904","article-title":"Effects of psilocybin therapy on personality structure","volume":"138","author":"Erritzoe","year":"2018","journal-title":"Acta Psychiatr. Scand."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1017\/S0033291718001356","article-title":"Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: A randomized placebo-controlled trial","volume":"49","author":"Barreto","year":"2019","journal-title":"Psychol. Med."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"de Almeida, R.N., Galv\u00e3o, A.C.M., da Silva, F.S., Silva, E.A.D.S., Palhano-Fontes, F., Maia-de-Oliveira, J.P., de Ara\u00fajo, L.B., Lob\u00e3o-Soares, B., and Galv\u00e3o-Coelho, N.L. (2019). Modulation of Serum Brain-Derived Neurotrophic Factor by a Single Dose of Ayahuasca: Observation from a Randomized Controlled Trial. Front. Psychol., 10.","DOI":"10.3389\/fpsyg.2019.01234"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Zeifman, R.J., Wagner, A.C., Watts, R., Kettner, H., Mertens, L.J., and Carhart-Harris, R.L. (2020). Post-Psychedelic Reductions in Experiential Avoidance Are Associated with Decreases in Depression Severity and Suicidal Ideation. Front. Psychiatry, 11.","DOI":"10.3389\/fpsyt.2020.00782"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial","volume":"78","author":"Davis","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Murphy, R., Kettner, H., Zeifman, R., Giribaldi, B., Kartner, L., Martell, J., Read, T., Murphy-Beiner, A., Baker-Jones, M., and Nutt, D. (2022). Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.788155"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1176\/appi.ajp.20231063","article-title":"Single-Dose Psilocybin for Depression with Severe Treatment Resistance: An Open-Label Trial","volume":"182","author":"Aaronson","year":"2025","journal-title":"Am. J. Psychiatry"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: A randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1177\/02698811221101061","article-title":"Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample","volume":"36","author":"Nygart","year":"2022","journal-title":"J. Psychopharmacol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1017\/S0033291723003653","article-title":"Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression","volume":"54","author":"Szigeti","year":"2024","journal-title":"Psychol. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00213-017-4820-5","article-title":"The hidden therapist: Evidence for a central role of music in psychedelic therapy","volume":"235","author":"Kaelen","year":"2018","journal-title":"Psychopharmacology"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"8833","DOI":"10.1038\/s41598-024-58318-x","article-title":"Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: Results from an exploratory placebo-controlled trial","volume":"14","author":"Sloshower","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1177\/0269881120936486","article-title":"Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca","volume":"34","author":"Perkins","year":"2020","journal-title":"J. Psychopharmacol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Levin, A.W., Lancelotta, R., Sepeda, N.D., Gukasyan, N., Nayak, S., Wagener, T.L., Barrett, F.S., Griffiths, R.R., and Davis, A.K. (2024). The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0300501"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s00213-023-06432-5","article-title":"Psilocybin therapy for treatment resistant depression: Prediction of clinical outcome by natural language processing","volume":"242","author":"Dougherty","year":"2025","journal-title":"Psychopharmacology"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jamapsychiatry.2024.4387","article-title":"Treatment Expectancies and Psilocybin vs Escitalopram for Depression","volume":"82","author":"Dutcher","year":"2025","journal-title":"JAMA Psychiatry"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1017\/S0033291723001514","article-title":"Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression","volume":"54","author":"Weiss","year":"2024","journal-title":"Psychol. Med."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Galv\u00e3o, A.C.M., de Almeida, R.N., Silva, E.A.D.S., Freire, F.A.M., Palhano-Fontes, F., Onias, H., Arcoverde, E., Maia-de-Oliveira, J.P., de Ara\u00fajo, D.B., and Lob\u00e3o-Soares, B. (2018). Cortisol Modulation by Ayahuasca in Patients with Treatment Resistant Depression and Healthy Controls. Front. Psychiatry, 9.","DOI":"10.3389\/fpsyt.2018.00185"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"de Sousa, G.M., de Oliveira Tavares, V.D., de Menezes Galv\u00e3o, A.C., de Almeida, R.N., Palhano-Fontes, F., Lob\u00e3o-Soares, B., de Morais Freire, F.A., Nunes, E.A., Maia-de-Oliveira, J.P., and Perkins, D. (2022). Moderators of ayahuasca\u2019s biological antidepressant action. Front. Psychiatry, 13.","DOI":"10.3389\/fpsyt.2022.1033816"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Earleywine, M., Mian, M.N., and De Leo, J.A. (2023). Expectancies for Subjective and Antidepressant Effects in Psilocybin Users. J. Humanist. Psychol.","DOI":"10.1177\/00221678231194798"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1192\/bjo.2022.565","article-title":"Effects of psilocybin versus escitalopram on rumination and thought suppression in depression","volume":"8","author":"Barba","year":"2022","journal-title":"BJPsych Open"},{"key":"ref_77","first-page":"215","article-title":"People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences","volume":"28","author":"Williams","year":"2021","journal-title":"Drugs"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jad.2023.04.105","article-title":"How does psilocybin therapy work? An exploration of experiential avoidance as a putative mechanism of change","volume":"334","author":"Zeifman","year":"2023","journal-title":"J. Affect. Disord."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1089\/psymed.2023.0030","article-title":"Psychedelic Use Among Psychiatric Medication Prescribers: Effects on Well-Being, Depression, Anxiety, and Associations with Patterns of Use, Reported Harms, and Transformative Mental States","volume":"1","author":"Herrmann","year":"2023","journal-title":"Psychedelic Med."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Raison, C.L., Jain, R., Penn, A.D., Cole, S.P., and Jain, S. (2022). Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being: Associations with Patterns of Use, Reported Harms, and Transformative Mental States. Front. Psychiatry, 13.","DOI":"10.3389\/fpsyt.2022.831092"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jcbs.2020.01.005","article-title":"Psychedelics and psychological flexibility\u2014Results of a prospective web-survey using the Acceptance and Action Questionnaire II","volume":"16","author":"Close","year":"2020","journal-title":"J. Context. Behav. Sci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00213-024-06733-3","article-title":"Moderating factors in psilocybin-assisted treatment affecting mood and personality: A naturalistic, open-label investigation","volume":"242","author":"Irrmischer","year":"2025","journal-title":"Psychopharmacology"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jad.2024.09.133","article-title":"Single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression\u2014A first-in-kind open-label pilot study","volume":"369","author":"Ellis","year":"2025","journal-title":"J. Affect. Disord."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"13187","DOI":"10.1038\/s41598-017-13282-7","article-title":"Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms","volume":"7","author":"Roseman","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.neuropharm.2017.12.041","article-title":"Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression","volume":"142","author":"Roseman","year":"2018","journal-title":"Neuropharmacology"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41591-022-01744-z","article-title":"Increased global integration in the brain after psilocybin therapy for depression","volume":"28","author":"Daws","year":"2022","journal-title":"Nat. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jad.2024.02.089","article-title":"Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivity","volume":"353","author":"Copa","year":"2024","journal-title":"J. Affect. Disord."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"fcae049","DOI":"10.1093\/braincomms\/fcae049","article-title":"Brain dynamics predictive of response to psilocybin for treatment-resistant depression","volume":"6","author":"Vohryzek","year":"2024","journal-title":"Brain Commun."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/02698811221125354","article-title":"Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression","volume":"37","author":"Shukuroglou","year":"2023","journal-title":"J. Psychopharmacol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jad.2023.04.081","article-title":"Increased low-frequency brain responses to music after psilocybin therapy for depression","volume":"333","author":"Wall","year":"2023","journal-title":"J. Affect. Disord."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s44220-024-00298-y","article-title":"Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depression","volume":"2","author":"Deco","year":"2024","journal-title":"Nat. Ment. Health"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/0269881119895520","article-title":"Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression","volume":"34","author":"Mertens","year":"2020","journal-title":"J. Psychopharmacol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1177\/02698811231179800","article-title":"Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms","volume":"37","author":"Skosnik","year":"2023","journal-title":"J. Psychopharmacol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e35082","DOI":"10.7554\/eLife.35082","article-title":"Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor","volume":"7","author":"Preller","year":"2018","journal-title":"Elife"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/pr.118.017160","article-title":"REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics","volume":"71","author":"Friston","year":"2019","journal-title":"Pharmacol. Rev."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.cub.2016.02.010","article-title":"Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution","volume":"26","author":"Tagliazucchi","year":"2016","journal-title":"Curr. Biol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1177\/0269881119855974","article-title":"Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory","volume":"33","author":"Roseman","year":"2019","journal-title":"J. Psychopharmacol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brat.2014.04.006","article-title":"Maximizing exposure therapy: An inhibitory learning approach","volume":"58","author":"Craske","year":"2014","journal-title":"Behav. Res. Ther."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"100945","DOI":"10.1016\/j.newideapsych.2022.100945","article-title":"Memory reconsolidation and the crisis of mechanism in psychotherapy","volume":"66","author":"Ecker","year":"2022","journal-title":"New Ideas Psychol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"103934","DOI":"10.1016\/j.nsa.2023.103934","article-title":"Amygdala response to emotional faces following acute administration of psilocybin in healthy individuals","volume":"3","author":"Armand","year":"2023","journal-title":"Neurosci. Appl."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.biopsych.2014.04.010","article-title":"Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers","volume":"78","author":"Kraehenmann","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.euroneuro.2016.03.018","article-title":"LSD modulates music-induced imagery via changes in parahippocampal connectivity","volume":"26","author":"Kaelen","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1007\/s00213-015-4014-y","article-title":"LSD enhances the emotional response to music","volume":"232","author":"Kaelen","year":"2015","journal-title":"Psychopharmacology"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1016\/j.neuron.2021.06.008","article-title":"Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo","volume":"109","author":"Shao","year":"2021","journal-title":"Neuron"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1177\/0269881116662634","article-title":"Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences","volume":"30","author":"Carbonaro","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1176\/appi.ajp.2007.07030504","article-title":"Functional neuroimaging of anxiety: A meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia","volume":"164","author":"Etkin","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.neuropharm.2012.06.007","article-title":"Stimulation of serotonin 2A receptors facilitates consolidation and extinction of fear memory in C57BL\/6J mice","volume":"64","author":"Zhang","year":"2013","journal-title":"Neuropharmacology"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1021\/acschemneuro.4c00279","article-title":"Psilocybin Facilitates Fear Extinction: Importance of Dose, Context, and Serotonin Receptors","volume":"15","author":"Woodburn","year":"2024","journal-title":"ACS Chem. Neurosci."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/da.21889","article-title":"The dissociative subtype of posttraumatic stress disorder: Rationale, clinical and neurobiological evidence, and implications","volume":"29","author":"Lanius","year":"2012","journal-title":"Depress. Anxiety"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Fink, G. (2017). Neuroendocrinology of posttraumatic stress disorder: Focus on the HPA axis. Stress: Neuroendocrinology and Neurobiology, Elsevier Academic Press.","DOI":"10.1016\/B978-0-12-802175-0.00001-2"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/00952990.2016.1170135","article-title":"Long-term follow-up of psilocybin-facilitated smoking cessation","volume":"43","author":"Johnson","year":"2017","journal-title":"Am. J. Drug Alcohol Abus."},{"key":"ref_112","first-page":"157","article-title":"Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction","volume":"7","author":"Griffiths","year":"2014","journal-title":"Curr. Drug Abus. Rev."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/0269881114565144","article-title":"Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study","volume":"29","author":"Bogenschutz","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1177\/0269881115609019","article-title":"Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin","volume":"29","author":"Barrett","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Beckman, M., Poulsen, S., Doss, M., and Stenb\u00e6k, D.S. (2023). Editorial: The psychotherapeutic framing of psychedelic drug administration. Front. Psychol., 14.","DOI":"10.3389\/fpsyg.2023.1121234"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1177\/0269881116677852","article-title":"Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology","volume":"30","author":"Hartogsohn","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Porges, S.W. (2022). Polyvagal Theory: A Science of Safety. Front. Integr. Neurosci., 16.","DOI":"10.3389\/fnint.2022.871227"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.copsyc.2014.12.021","article-title":"Social Baseline Theory: The Social Regulation of Risk and Effort","volume":"1","author":"Coan","year":"2015","journal-title":"Curr. Opin. Psychol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/j.1467-9280.2006.01832.x","article-title":"Lending a hand: Social regulation of the neural response to threat","volume":"17","author":"Coan","year":"2006","journal-title":"Psychol. Sci."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1037\/ccp0000637","article-title":"Examining therapist effects in the alliance-outcome relationship: A multilevel meta-analysis","volume":"89","author":"Horvath","year":"2021","journal-title":"J. Consult. Clin. Psychol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1037\/a0032258","article-title":"Therapeutic alliance predicts symptomatic improvement session by session","volume":"60","author":"Holmqvist","year":"2013","journal-title":"J. Couns. Psychol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1037\/ccp0000594","article-title":"The reciprocal relationship between alliance and early treatment symptoms: A two-stage individual participant data meta-analysis","volume":"88","author":"Rubel","year":"2020","journal-title":"J. Consult. Clin. Psychol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"e1978","DOI":"10.1002\/mpr.1978","article-title":"Synchrony in psychotherapy: High physiological positive concordance predicts symptom reduction and negative concordance predicts symptom aggravation","volume":"33","author":"Gernert","year":"2023","journal-title":"Int. J. Methods Psychiatr. Res."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Koole, S.L., and Tschacher, W. (2016). Synchrony in Psychotherapy: A Review and an Integrative Framework for the Therapeutic Alliance. Front. Psychol., 7.","DOI":"10.3389\/fpsyg.2016.00862"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1037\/pst0000175","article-title":"Therapist empathy and client outcome: An updated meta-analysis","volume":"55","author":"Elliott","year":"2018","journal-title":"Psychotherapy"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jad.2020.02.013","article-title":"Antidepressant-placebo differences for specific adverse events in major depressive disorder: A systematic review","volume":"267","author":"Sinyor","year":"2020","journal-title":"J. Affect. Disord."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Rojas-Mirquez, J.C., Rodriguez-Zu\u00f1iga, M.J., Bonilla-Escobar, F.J., Garcia-Perdomo, H.A., Petkov, M., Becerra, L., Borsook, D., and Linnman, C. (2014). Nocebo effect in randomized clinical trials of antidepressants in children and adolescents: Systematic review and meta-analysis. Front. Behav. Neurosci., 8.","DOI":"10.3389\/fnbeh.2014.00375"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s00213-019-05448-0","article-title":"Cognitive neuropsychological theory of antidepressant action: A modern-day approach to depression and its treatment","volume":"238","author":"Godlewska","year":"2021","journal-title":"Psychopharmacology"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"20120407","DOI":"10.1098\/rstb.2012.0407","article-title":"\u2018It\u2019s the way that you look at it\u2019\u2014A cognitive neuropsychological account of SSRI action in depression","volume":"368","author":"Harmer","year":"2013","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/sj.npp.1300004","article-title":"Acute SSRI administration affects the processing of social cues in healthy volunteers","volume":"28","author":"Harmer","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/archgenpsychiatry.2010.88","article-title":"Effects of expectation on placebo-induced dopamine release in Parkinson disease","volume":"67","author":"Lidstone","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1126\/science.1060937","article-title":"Expectation and dopamine release: Mechanism of the placebo effect in Parkinson\u2019s disease","volume":"293","author":"Ruth","year":"2001","journal-title":"Science"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev-pharmtox-010818-021542","article-title":"The Placebo Effect in Pain Therapies","volume":"59","author":"Colloca","year":"2019","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"70ra14","DOI":"10.1126\/scitranslmed.3001244","article-title":"The effect of treatment expectation on drug efficacy: Imaging the analgesic benefit of the opioid remifentanil","volume":"3","author":"Bingel","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1007\/s00213-022-06221-6","article-title":"Expectancy in placebo-controlled trials of psychedelics: If so, so what?","volume":"239","author":"Butler","year":"2022","journal-title":"Psychopharmacology"},{"key":"ref_136","first-page":"512","article-title":"Expectancy Effects in Psychedelic Trials","volume":"9","author":"Szigeti","year":"2024","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1177\/02698811231180276","article-title":"Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review","volume":"37","author":"Hovmand","year":"2023","journal-title":"J. Psychopharmacol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1001\/archgenpsychiatry.2011.2190","article-title":"Functional brain basis of hypnotizability","volume":"69","author":"Hoeft","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"B\u0103l\u0103e\u0163, M. (2022). Psychedelic Cognition-The Unreached Frontier of Psychedelic Science. Front. Neurosci., 16.","DOI":"10.3389\/fnins.2022.832375"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/npp.2017.86","article-title":"Modern Clinical Research on LSD","volume":"42","author":"Liechti","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00213-014-3714-z","article-title":"LSD enhances suggestibility in healthy volunteers","volume":"232","author":"Kaelen","year":"2015","journal-title":"Psychopharmacology"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.2147\/NDT.S426193","article-title":"Predicting the Intensity of Psychedelic-Induced Mystical and Challenging Experience in a Healthy Population: An Exploratory Post-Hoc Analysis","volume":"19","author":"Ko","year":"2023","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Haijen, E.C.H.M., Kaelen, M., Roseman, L., Timmermann, C., Kettner, H., Russ, S., Nutt, D., Daws, R.E., Hampshire, A.D.G., and Lorenz, R. (2018). Predicting Responses to Psychedelics: A Prospective Study. Front. Pharmacol., 9.","DOI":"10.3389\/fphar.2018.00897"},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Studerus, E., Gamma, A., Kometer, M., and Vollenweider, F.X. (2012). Prediction of psilocybin response in healthy volunteers. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0030800"},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Himmelstein, P., Barb, S., Finlayson, M.A., and Young, K.D. (2018). Linguistic analysis of the autobiographical memories of individuals with major depressive disorder. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0207814"},{"key":"ref_146","first-page":"39","article-title":"Linguistic features in depression: A meta-analysis","volume":"4","year":"2019","journal-title":"J. Lang. Work.-Sprogvidenskabeligt Stud."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1037\/bul0000385","article-title":"We know this much is (meta-analytically) true: A meta-review of meta-analytic findings evaluating self-determination theory","volume":"148","author":"Ryan","year":"2022","journal-title":"Psychol. Bull."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1080\/17437199.2020.1718529","article-title":"A meta-analysis of self-determination theory-informed intervention studies in the health domain: Effects on motivation, health behavior, physical, and psychological health","volume":"15","author":"Ntoumanis","year":"2020","journal-title":"Health Psychol. Rev."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"E1652","DOI":"10.1073\/pnas.1502295112","article-title":"Facilitation of fear extinction by novelty depends on dopamine acting on D1-subtype dopamine receptors in hippocampus","volume":"112","author":"Menezes","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.tins.2018.10.002","article-title":"Novelty and Dopaminergic Modulation of Memory Persistence: A Tale of Two Systems","volume":"42","author":"Duszkiewicz","year":"2019","journal-title":"Trends Neurosci."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1021\/acschemneuro.2c00170","article-title":"Tolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT2A Receptor Agonists in Mice","volume":"13","author":"Jaster","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Banushi, B., and Polito, V.A. (2023). Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics. Biology, 12.","DOI":"10.3390\/biology12111380"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"e2727","DOI":"10.7717\/peerj.2727","article-title":"Harmine stimulates proliferation of human neural progenitors","volume":"4","author":"Dakic","year":"2016","journal-title":"PeerJ"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.yfrne.2009.03.002","article-title":"Glucocorticoids and the regulation of memory in health and disease","volume":"30","author":"Aerni","year":"2009","journal-title":"Front. Neuroendocr."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00213-018-5116-0","article-title":"Glucocorticoid-induced enhancement of extinction\u2014From animal models to clinical trials","volume":"236","author":"Wolf","year":"2019","journal-title":"Psychopharmacology"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.psyneuen.2013.01.001","article-title":"For whom the bell (curve) tolls: Cortisol rapidly affects memory retrieval by an inverted U-shaped dose-response relationship","volume":"38","author":"Schilling","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/jpet.108.143461","article-title":"Serotonin 5-hydroxytryptamine(2A) receptor activation suppresses tumor necrosis factor-alpha-induced inflammation with extraordinary potency","volume":"327","author":"Yu","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Nau, F., Yu, B., Martin, D., and Nichols, C.D. (2013). Serotonin 5-HT2A receptor activation blocks TNF-\u03b1 mediated inflammation in vivo. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0075426"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1021\/acsptsci.3c00297","article-title":"Serotonin-2 Receptor Agonists Produce Anti-inflammatory Effects through Functionally Selective Mechanisms That Involve the Suppression of Disease-Induced Arginase 1 Expression","volume":"7","author":"Flanagan","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Szabo, A., Kovacs, A., Frecska, E., and Rajnavolgyi, E. (2014). Psychedelic N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine modulate innate and adaptive inflammatory responses through the sigma-1 receptor of human monocyte-derived dendritic cells. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0106533"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"12863","DOI":"10.1038\/s41598-017-12779-5","article-title":"Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT","volume":"7","author":"Dakic","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/0885066610384188","article-title":"Interleukin-6 in surgery, trauma, and critical care part II: Clinical implications","volume":"26","author":"Jawa","year":"2011","journal-title":"J. Intensive Care Med."},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Nilsonne, G., Lekander, M., \u00c5kerstedt, T., Axelsson, J., and Ingre, M. (2016). Diurnal Variation of Circulating Interleukin-6 in Humans: A Meta-Analysis. PLoS ONE, 11.","DOI":"10.1101\/042507"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1172\/JCI200318921","article-title":"C-reactive protein: A critical update","volume":"111","author":"Pepys","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1176\/appi.ajp.160.9.1554","article-title":"When not enough is too much: The role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders","volume":"160","author":"Raison","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.beth.2012.05.003","article-title":"The impact of treatment components suggested by the psychological flexibility model: A meta-analysis of laboratory-based component studies","volume":"43","author":"Levin","year":"2012","journal-title":"Behav. Ther."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.beth.2011.03.007","article-title":"Preliminary psychometric properties of the Acceptance and Action Questionnaire-II: A revised measure of psychological inflexibility and experiential avoidance","volume":"42","author":"Bond","year":"2011","journal-title":"Behav. Ther."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.cpr.2010.03.001","article-title":"Psychological flexibility as a fundamental aspect of health","volume":"30","author":"Kashdan","year":"2010","journal-title":"Clin. Psychol. Rev."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nature08637","article-title":"Preventing the return of fear in humans using reconsolidation update mechanisms","volume":"463","author":"Schiller","year":"2010","journal-title":"Nature"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cpr.2012.01.001","article-title":"Psychopathology and thought suppression: A quantitative review","volume":"32","author":"Magee","year":"2012","journal-title":"Clin. Psychol. Rev."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1745-6924.2008.00088.x","article-title":"Rethinking Rumination","volume":"3","author":"Wisco","year":"2008","journal-title":"Perspect. Psychol. Sci."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.brat.2010.12.006","article-title":"Rumination as a transdiagnostic factor in depression and anxiety","volume":"49","author":"McLaughlin","year":"2011","journal-title":"Behav. Res. Ther."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/nyas.12360","article-title":"The default network and self-generated thought: Component processes, dynamic control, and clinical relevance","volume":"1316","author":"Smallwood","year":"2014","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41586-024-07624-5","article-title":"Psilocybin desynchronizes the human brain","volume":"632","author":"Siegel","year":"2024","journal-title":"Nature"},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Capaldi, C.A., Dopko, R.L., and Zelenski, J.M. (2014). The relationship between nature connectedness and happiness: A meta-analysis. Front. Psychol., 5.","DOI":"10.3389\/fpsyg.2014.00976"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/1754073916684557","article-title":"Self-transcendent emotions and their social functions: Compassion, gratitude, and awe bind us to others through prosociality","volume":"9","author":"Stellar","year":"2017","journal-title":"Emot. Rev."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1037\/pspi0000018","article-title":"Awe, the small self, and prosocial behavior","volume":"108","author":"Piff","year":"2015","journal-title":"J. Pers. Soc. Psychol."},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Holt-Lunstad, J., Smith, T.B., and Layton, J.B. (2010). Social relationships and mortality risk: A meta-analytic review. PLoS Med., 7.","DOI":"10.4016\/19865.01"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/s41386-019-0324-9","article-title":"Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels","volume":"44","author":"Madsen","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"119220","DOI":"10.1016\/j.neuroimage.2022.119220","article-title":"Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex","volume":"256","author":"Girn","year":"2022","journal-title":"Neuroimage"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"5812","DOI":"10.1038\/s41467-022-33578-1","article-title":"Receptor-informed network control theory links LSD and psilocybin to a flattening of the brain\u2019s control energy landscape","volume":"13","author":"Singleton","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"117653","DOI":"10.1016\/j.neuroimage.2020.117653","article-title":"LSD alters dynamic integration and segregation in the human brain","volume":"227","author":"Luppi","year":"2021","journal-title":"Neuroimage"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1073\/pnas.1815129116","article-title":"Effective connectivity changes in LSD-induced altered states of consciousness in humans","volume":"116","author":"Preller","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"102388","DOI":"10.1016\/j.nicl.2020.102388","article-title":"Response to SSRI intervention and amygdala activity during self-referential processing in major depressive disorder","volume":"28","author":"Young","year":"2020","journal-title":"Neuroimage Clin."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1192\/bjp.bp.108.056093","article-title":"Effect of a single dose of citalopram on amygdala response to emotional faces","volume":"194","author":"Murphy","year":"2009","journal-title":"Br. J. Psychiatry"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1038\/s41380-022-01715-3","article-title":"Functional connectivity in reward circuitry and symptoms of anhedonia as therapeutic targets in depression with high inflammation: Evidence from a dopamine challenge study","volume":"27","author":"Bekhbat","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41398-022-01995-x","article-title":"Reduced nucleus accumbens functional connectivity in reward network and default mode network in patients with recurrent major depressive disorder","volume":"12","author":"Ding","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"10430","DOI":"10.1073\/pnas.1301228110","article-title":"From perception to pleasure: Music and its neural substrates","volume":"110","author":"Zatorre","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nn.2726","article-title":"Anatomically distinct dopamine release during anticipation and experience of peak emotion to music","volume":"14","author":"Salimpoor","year":"2011","journal-title":"Nat. Neurosci."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1073\/pnas.1518377113","article-title":"Neural correlates of the LSD experience revealed by multimodal neuroimaging","volume":"113","author":"Muthukumaraswamy","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"9078","DOI":"10.1073\/pnas.1900390116","article-title":"Reduced default mode network functional connectivity in patients with recurrent major depressive disorder","volume":"116","author":"Yan","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.biopsych.2015.02.020","article-title":"Depressive Rumination, the Default-Mode Network, and the Dark Matter of Clinical Neuroscience","volume":"78","author":"Hamilton","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jamapsychiatry.2015.0071","article-title":"Large-Scale Network Dysfunction in Major Depressive Disorder: A Meta-analysis of Resting-State Functional Connectivity","volume":"72","author":"Kaiser","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"eadf8332","DOI":"10.1126\/sciadv.adf8332","article-title":"In vivo mapping of pharmacologically induced functional reorganization onto the human brain\u2019s neurotransmitter landscape","volume":"9","author":"Luppi","year":"2023","journal-title":"Sci. Adv."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"17661","DOI":"10.1038\/s41598-017-17546-0","article-title":"Connectome-harmonic decomposition of human brain activity reveals dynamical repertoire re-organization under LSD","volume":"7","author":"Atasoy","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1073\/pnas.95.2.735","article-title":"5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: Possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites","volume":"95","author":"Jakab","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_198","doi-asserted-by":"crossref","unstructured":"Raval, N.R., Johansen, A., Donovan, L.L., Ros, N.F., Ozenne, B., Hansen, H.D., and Knudsen, G.M. (2021). A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain. Int. J. Mol. Sci., 22.","DOI":"10.20944\/preprints202011.0742.v1"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/brain\/awab406","article-title":"Models of psychedelic drug action: Modulation of cortical-subcortical circuits","volume":"145","author":"Doss","year":"2022","journal-title":"Brain"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"10544","DOI":"10.1523\/JNEUROSCI.3007-12.2013","article-title":"Activation of serotonin 2A receptors underlies the psilocybin-induced effects on \u03b1 oscillations, N170 visual-evoked potentials, and visual hallucinations","volume":"33","author":"Kometer","year":"2013","journal-title":"J. Neurosci."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1038\/s41467-025-59417-7","article-title":"Closed-loop control of theta oscillations enhances human hippocampal network connectivity","volume":"16","author":"Kragel","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1523\/JNEUROSCI.3629-15.2016","article-title":"Theta-Alpha Oscillations Bind the Hippocampus, Prefrontal Cortex, and Striatum during Recollection: Evidence from Simultaneous EEG-fMRI","volume":"36","author":"Herweg","year":"2016","journal-title":"J. Neurosci."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.tics.2019.12.006","article-title":"Theta Oscillations in Human Memory","volume":"24","author":"Herweg","year":"2020","journal-title":"Trends Cogn. Sci."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41467-019-09562-7","article-title":"Lower synaptic density is associated with depression severity and network alterations","volume":"10","author":"Holmes","year":"2019","journal-title":"Nat. Commun."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/5\/2202\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T13:59:07Z","timestamp":1772114347000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/5\/2202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":204,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["ijms27052202"],"URL":"https:\/\/doi.org\/10.3390\/ijms27052202","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]}}}